(#4 of 11): Acentrus Specialty Conference | ASHP Leadership & Opportunities for Member Engagement
Join the discussion from the Acentrus Speciality Conference 2021 on ASHP leadership and opportunities for member engagement with David Chen, RPh, MBA, Assistant Vice President for Pharmacy Leadership & Planning, ASHP. Learn more about Acentrus Specialty here: acentrusrx.com. Learn more about RXinsider and our Video Solutions here: rxinsider.com.
(#5 of 11): Acentrus Specialty Conference | Integrating Clinical & Specialty Pharmacy
Join the discussion from the Acentrus Speciality Conference 2021 on integrating clinical and specialty pharmacy with Meagan Fowler, PharmD, MSHA, BCPS, UAB Medicine, David Mitchell, PharmD, MBA, UC Davis Health, and Lanh Dang, PharmD, BCAPC, UF Health Jacksonville. Learn more about Acentrus Specialty here: acentrusrx.com. Learn more about RXinsider and our Video Solutions here: rxinsider.com.
(#6 of 11): Acentrus Specialty Conference | Overcoming the Payer Problem
Join the discussion from the Acentrus Speciality Conference 2021 on overcoming the payer problem with Steve Zabriski, BS Pharm, MBA, Acrentrus Specialty, Lindsey Amerine, PharmD, MS, BCPS, FASHP, UNC Health, Glen Wachter, MBA, MPA, Providence AVP for Pharmacy Creda Health, and Dusty Lewis, PharmD, MBA, LoopBack Analytics. Learn more about Acentrus Specialty here: acentrusrx.com. Learn […]
(#7 of 11): Acentrus Specialty Conference | Expanding into Home Infusion
Join the discussion from the Acentrus Speciality Conference 2021 on expanding into home infusion with Tom Altenberger, RPh, MBA, Acentrus Specialty, Steve Kennedy, PharmD, CSP, Vizient, Scott Sterrett, PharmD, Beaumont Health, and Scott Copple, RPh, Mercy Pharmacy Services. Learn more about Acentrus Specialty here: acentrusrx.com. Learn more about RXinsider and our Video Solutions here: rxinsider.com.
(#8 of 11): Acentrus Specialty Conference | Pipeline Power
Join the discussion from the Acentrus Speciality Conference 2021 on pipeline power with Pedram Pahlavan, PharmD, Acentrus Specialty, Time Hinkley, PharmD, BCPS, Froedtert, Jeff Reichard, PharmD, MS, BCPS, University of North Carolina Hospitals – Chapel Hill, and Julia Chisholm, PharmD, MBA, AAHIVP, University of Missouri Health Care. Learn more about Acentrus Specialty here: acentrusrx.com. Learn […]
(#9 of 11): Acentrus Specialty Conference | Specialty Pharmacy Trends
Join the discussion from the Acentrus Speciality Conference 2021 on specialty pharmacy trends with Karl Karlsson, PhD, Principal & General Manager, SG2, and Jeff Moser, Principal, SG2. Learn more about Acentrus Specialty here: acentrusrx.com. Learn more about RXinsider and our Video Solutions here: rxinsider.com.
(#10 of 11): Acentrus Specialty Conference | Advancing Your Strategy for Success
Join the discussion from the Acentrus Speciality Conference 2021 on advancing your strategy for success with George Zula, RPh, MBA, CPS, Acentrus Specialty, Robert Scholz, RPh, MS, MBA, Acentrus Specialty, Neil Smiley, LoopBack Analytics, and Chris Hatwig, MS, RPh, FASHP, Apexus. Learn more about Acentrus Specialty here: acentrusrx.com. Learn more about RXinsider and our Video […]
(#11 of 11): Acentrus Specialty Conference | Understanding Value From All Perspectives
Join the discussion from the Acentrus Speciality Conference 2021 with Pedram Pahlavan, PharmD, Acentrus Specialty, Kevin Cast, MS, Archbow Consulting, Sarah Daniel, PharmD, MS, BCPS, The University of Kansas Health System, Kay Ryan, DPH, MS, MBA, FAHP, Regional One Health, and Dean Erhardt, MBA, D2 Consulting. Learn more about Acentrus Specialty here: acentrusrx.com. Learn more […]
(#5 of 5): Why Choose Azina?
Join Keith Cook, President, as he discusses why hospitals/health systems should choose Azina to be their partner in specialty pharmacy.
(#17 of 18): What support does Visante offer for prior authorizations?
#17: What support does Visante offer for prior authorizations? Join Joe Cesarz, Vice President, Hospitals & Health Systems, as he discusses the support offered by Visante for prior authorizations including benefit investigation, prior authorization submission, free drug program enrollment, and more.
